BPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT05393466
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-small Cell Lung Carcinoma
Interventions
DRUG:
BPI-361175
Sponsor
Xcovery Holdings, Inc.